nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR1—thoracic aortic aneurysm	0.0958	0.0966	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR2—thoracic aortic aneurysm	0.068	0.0685	CbGpPWpGaD
Everolimus—FKBP1A—ALK1 signaling events—TGFBR1—thoracic aortic aneurysm	0.065	0.0655	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR1—thoracic aortic aneurysm	0.0551	0.0555	CbGpPWpGaD
Everolimus—FKBP1A—ALK1 signaling events—TGFBR2—thoracic aortic aneurysm	0.0461	0.0464	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR2—thoracic aortic aneurysm	0.039	0.0393	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—TGFBR1—thoracic aortic aneurysm	0.0373	0.0376	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR1—thoracic aortic aneurysm	0.0362	0.0365	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—thoracic aortic aneurysm	0.0345	0.0348	CbGpPWpGaD
Everolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR1—thoracic aortic aneurysm	0.0326	0.0329	CbGpPWpGaD
Everolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB2—thoracic aortic aneurysm	0.0313	0.0315	CbGpPWpGaD
Everolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR1—thoracic aortic aneurysm	0.0294	0.0297	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—TGFBR2—thoracic aortic aneurysm	0.0265	0.0267	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR2—thoracic aortic aneurysm	0.0257	0.0259	CbGpPWpGaD
Everolimus—MTOR—Cardiac Hypertrophic Response—PRKG1—thoracic aortic aneurysm	0.0242	0.0244	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—thoracic aortic aneurysm	0.0234	0.0236	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—MYLK—thoracic aortic aneurysm	0.0234	0.0236	CbGpPWpGaD
Everolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—thoracic aortic aneurysm	0.0231	0.0233	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—thoracic aortic aneurysm	0.0227	0.0229	CbGpPWpGaD
Everolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR2—thoracic aortic aneurysm	0.0209	0.021	CbGpPWpGaD
Everolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—thoracic aortic aneurysm	0.0205	0.0206	CbGpPWpGaD
Everolimus—MTOR—Cardiac Hypertrophic Response—TGFBR1—thoracic aortic aneurysm	0.0201	0.0202	CbGpPWpGaD
Everolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—thoracic aortic aneurysm	0.0185	0.0186	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—PRKG1—thoracic aortic aneurysm	0.0173	0.0174	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.0132	0.0133	CbGpPWpGaD
Everolimus—MTOR—Regulation of Telomerase—SMAD3—thoracic aortic aneurysm	0.0106	0.0107	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—ADAM17—thoracic aortic aneurysm	0.00929	0.00937	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00895	0.00902	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—ADAM17—thoracic aortic aneurysm	0.0089	0.00897	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—ADAM17—thoracic aortic aneurysm	0.00781	0.00787	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—ADAM17—thoracic aortic aneurysm	0.00774	0.0078	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—thoracic aortic aneurysm	0.00751	0.00756	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR2—thoracic aortic aneurysm	0.00635	0.00639	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—MMP9—thoracic aortic aneurysm	0.00625	0.00629	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.00599	0.00603	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.00593	0.00598	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00537	0.00541	CbGpPWpGaD
Everolimus—MTOR—leg—thoracic aortic aneurysm	0.00533	0.699	CbGeAlD
Everolimus—MTOR—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.00461	0.00465	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00355	0.00358	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00305	0.00307	CbGpPWpGaD
Everolimus—FKBP1A—Disease—ADAM17—thoracic aortic aneurysm	0.00293	0.00295	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFBR1—thoracic aortic aneurysm	0.00293	0.00295	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.00247	0.00249	CbGpPWpGaD
Everolimus—FKBP1A—Disease—ADAM10—thoracic aortic aneurysm	0.00224	0.00226	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRKG1—thoracic aortic aneurysm	0.00215	0.00217	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFBR2—thoracic aortic aneurysm	0.00208	0.00209	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00205	0.00207	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00205	0.00207	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SMAD3—thoracic aortic aneurysm	0.00184	0.00185	CbGpPWpGaD
Everolimus—MTOR—Immune System—ADAM17—thoracic aortic aneurysm	0.00178	0.0018	CbGpPWpGaD
Everolimus—MTOR—Disease—ADAM17—thoracic aortic aneurysm	0.00165	0.00166	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFBR1—thoracic aortic aneurysm	0.00165	0.00166	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.00157	0.00158	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.00145	0.00147	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.00139	0.0014	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.00129	0.0013	CbGpPWpGaD
Everolimus—MTOR—Disease—ADAM10—thoracic aortic aneurysm	0.00126	0.00127	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFBR2—thoracic aortic aneurysm	0.00117	0.00118	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00115	0.00116	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00115	0.00116	CbGpPWpGaD
Everolimus—MTOR—Disease—SMAD3—thoracic aortic aneurysm	0.00103	0.00104	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000884	0.000891	CbGpPWpGaD
Everolimus—FKBP1A—cardiac atrium—thoracic aortic aneurysm	0.000826	0.108	CbGeAlD
Everolimus—MTOR—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000818	0.000824	CbGpPWpGaD
Everolimus—MTOR—spinal cord—thoracic aortic aneurysm	0.000772	0.101	CbGeAlD
Everolimus—MTOR—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000723	0.000729	CbGpPWpGaD
Everolimus—FKBP1A—spinal cord—thoracic aortic aneurysm	0.000694	0.0911	CbGeAlD
Everolimus—FKBP1A—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000661	0.000666	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000372	0.000374	CbGpPWpGaD
